# [Necrotic Enteritis in Poultry](/knowledge/bacteria/avian-bacteria/necrotic-enteritis-in-poultry): Pathogenesis and Control

## Key Takeaways

- Necrotic enteritis (NE) is an economically significant enteric disease in poultry, primarily caused by toxigenic strains of *Clostridium perfringens* (types A and C), characterized by acute intestinal mucosal necrosis.
- The pathogenesis is multifactorial, requiring predisposing factors such as coccidial infections (*Eimeria* spp.), dietary stress (high non-starch polysaccharides), or immunosuppression to trigger outbreaks.
- Key virulence factors of *C. perfringens* include alpha-toxin (CPA), a phospholipase C, and NetB toxin, a pore-forming toxin critical for intestinal epithelial cell lysis and necrosis.
- Clinical signs range from acute mortality with depression and bloody diarrhea to a subclinical form with reduced feed conversion and impaired growth, often exacerbated by concurrent coccidiosis.
- Diagnosis relies on clinical signs, gross pathology (intestinal pseudomembranes), histopathology (villar necrosis), and microbiological confirmation via anaerobic culture and PCR for toxin genes.
- Integrated control strategies are essential, focusing on biosecurity, rigorous coccidiosis control (vaccination or anticoccidials), dietary modifications (enzyme supplementation, reduced NSP), and the judicious use of probiotics and prebiotics.

---

## Introduction

[Necrotic enteritis](/knowledge/bacteria/avian-bacteria/necrotic-enteritis-poultry) (NE) is an economically significant enteric disease of poultry, primarily affecting broiler chickens, though turkeys and other avian species are also susceptible [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>]. The disease is characterized by acute necrosis of the intestinal mucosa, leading to decreased feed conversion, increased mortality, and substantial economic losses in commercial flocks [<a href="#ref-1">1</a>, <a href="#ref-3">3</a>]. Understanding the multifactorial pathogenesis of NE is essential for designing effective control programs. This article provides a detailed review of the etiology, epidemiology, clinical presentation, pathology, diagnostic approaches, treatment options, and integrated control strategies for [necrotic enteritis in poultry](/knowledge/bacteria/avian-bacteria/necrotic-enteritis-in-poultry).

## What is [Necrotic Enteritis](/knowledge/bacteria/avian-bacteria/poultry-necrotic-enteritis-pathogenesis-control)?

[Necrotic enteritis](/knowledge/bacteria/avian-bacteria/necrotic-enteritis-poultry) is an enterotoxemic disease caused by toxigenic strains of *Clostridium perfringens*, most commonly type A and, less frequently, type C [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>]. The disease manifests in two forms: an acute clinical form with sudden mortality and a subclinical form characterized by chronic intestinal damage without overt mortality [<a href="#ref-3">3</a>]. The subclinical form is often more economically damaging due to impaired growth performance and increased feed conversion ratios [<a href="#ref-3">3</a>]. NE is a classic example of a multifactorial disease, requiring predisposing factors such as coccidial infection, dietary stress, or immunosuppression to trigger clinical outbreaks [<a href="#ref-1">1</a>, <a href="#ref-4">4</a>].

## Etiology

The primary causative agent is *Clostridium perfringens*, a Gram-positive, spore-forming, anaerobic rod [<a href="#ref-1">1</a>]. *C. perfringens* is a normal inhabitant of the poultry intestinal tract, typically present at low levels (10^2 to 10^4 CFU/g of intestinal content) [<a href="#ref-2">2</a>]. Disease occurs when conditions favor the overgrowth of toxigenic strains, particularly those producing the alpha-toxin (CPA) and the NetB toxin (NetB) [<a href="#ref-1">1</a>, <a href="#ref-5">5</a>]. Alpha-toxin is a phospholipase C that hydrolyzes membrane phospholipids, causing cell lysis and necrosis [<a href="#ref-5">5</a>]. NetB is a pore-forming toxin that disrupts intestinal epithelial cells and is considered a critical virulence factor for NE in broilers [<a href="#ref-5">5</a>, <a href="#ref-6">6</a>]. Type C strains produce beta-toxin, which is associated with hemorrhagic enteritis in neonatal animals but is less common in poultry [<a href="#ref-1">1</a>].

## Epidemiology

NE occurs worldwide in commercial poultry operations, with broiler chickens being the most affected [<a href="#ref-1">1</a>, <a href="#ref-3">3</a>]. The disease is most commonly observed in birds between 2 and 6 weeks of age, coinciding with the period of highest growth rate and dietary changes [<a href="#ref-2">2</a>]. Outbreaks are often sporadic and associated with management factors such as high stocking density, poor litter quality, and abrupt feed changes [<a href="#ref-3">3</a>]. The use of antimicrobial growth promoters historically controlled NE, but their withdrawal in many regions has led to a resurgence of the disease [<a href="#ref-4">4</a>, <a href="#ref-6">6</a>].

### Predisposing Factors

The development of NE requires a convergence of predisposing factors that disrupt the intestinal ecosystem [<a href="#ref-1">1</a>, <a href="#ref-4">4</a>]. The most important predisposing factor is coccidiosis, caused by *Eimeria* species [<a href="#ref-4">4</a>]. Coccidial infection damages the intestinal epithelium, providing a rich substrate for *C. perfringens* proliferation and toxin production [<a href="#ref-4">4</a>]. Dietary factors, such as high levels of non-starch polysaccharides (e.g., wheat, barley, rye) and animal protein sources, can increase intestinal viscosity and provide fermentable substrates for clostridial growth [<a href="#ref-2">2</a>, <a href="#ref-3">3</a>]. Immunosuppressive agents, including [infectious bursal disease virus](/knowledge/viruses/avian-viruses/infectious-bursal-disease-virus) and mycotoxins, also increase susceptibility [<a href="#ref-1">1</a>].

### [Chicken Parasites in Eggs](/knowledge/parasites/avian-parasites/parasites-poultry-eggs-risks) and Meat

While NE is a bacterial disease, it is important to distinguish it from parasitic conditions that may affect poultry products. The term "[chicken parasites in eggs](/knowledge/parasites/avian-parasites/parasites-poultry-worms-mites-eggs)" typically refers to infestations by *[Dermanyssus gallinae](/knowledge/parasites/avian-parasites/dermanyssus-gallinae)* (poultry red mite) or *[Ornithonyssus sylviarum](/knowledge/parasites/avian-parasites/ornithonyssus-sylviarum-northern-fowl-mite-poultry)* (northern fowl mite), which can cause anemia and reduced egg production but are not directly associated with NE [<a href="#ref-7">7</a>]. Similarly, "[chicken parasites in meat](/knowledge/parasites/avian-parasites/parasites-poultry-chicken-eggs-meat)" may refer to *[Toxoplasma gondii](/knowledge/parasites/protozoa/toxoplasma-gondii-lifecycle-neurological-infection)* or *Sarcocystis* species, though these are not primary concerns in commercial broiler production [<a href="#ref-7">7</a>]. However, coccidiosis (caused by *Eimeria* species) is a key predisposing factor for NE and is a common parasitic disease in poultry [<a href="#ref-4">4</a>]. Effective control of coccidiosis through vaccination or anticoccidial drugs is a cornerstone of NE prevention [<a href="#ref-4">4</a>, <a href="#ref-8">8</a>].

## Pathogenesis

The pathogenesis of NE involves a sequence of events that lead to intestinal dysbiosis and toxin-mediated necrosis [<a href="#ref-1">1</a>, <a href="#ref-5">5</a>]. Under normal conditions, the intestinal microbiota suppresses *C. perfringens* overgrowth through competitive exclusion and production of inhibitory metabolites [<a href="#ref-2">2</a>]. Predisposing factors disrupt this balance, allowing *C. perfringens* to proliferate to high numbers (10^7 to 10^9 CFU/g) [<a href="#ref-2">2</a>].

### Molecular Mechanisms

Once established, toxigenic *C. perfringens* produces alpha-toxin and NetB toxin [<a href="#ref-5">5</a>]. Alpha-toxin (CPA) is a zinc-dependent phospholipase C that cleaves phosphatidylcholine and sphingomyelin in host cell membranes, leading to membrane disruption, cell lysis, and necrosis [<a href="#ref-5">5</a>]. NetB toxin forms heptameric pores in the plasma membrane of intestinal epithelial cells, causing osmotic lysis and cell death [<a href="#ref-5">5</a>, <a href="#ref-6">6</a>]. The combined action of these toxins results in extensive mucosal necrosis, hemorrhage, and fibrin deposition [<a href="#ref-1">1</a>]. The damaged mucosa allows further bacterial translocation and toxin absorption, leading to systemic toxemia and death in severe cases [<a href="#ref-1">1</a>].

### Role of the Gut Microbiome

The gut microbiome plays a critical role in NE pathogenesis [<a href="#ref-2">2</a>, <a href="#ref-9">9</a>]. A healthy microbiome, dominated by lactic acid bacteria and *Bacteroides* species, inhibits *C. perfringens* through competition for nutrients and production of short-chain fatty acids [<a href="#ref-2">2</a>]. Dietary and environmental stressors alter the microbiome composition, favoring *C. perfringens* expansion [<a href="#ref-9">9</a>]. Probiotic supplementation with *Lactobacillus* or *Bacillus* species has been shown to reduce *C. perfringens* colonization and NE severity [<a href="#ref-9">9</a>, <a href="#ref-10">10</a>].

## Clinical Signs

The clinical presentation of NE varies with the form of the disease [<a href="#ref-1">1</a>, <a href="#ref-3">3</a>].

### Acute Form

Acute NE is characterized by sudden onset of depression, anorexia, ruffled feathers, diarrhea (often dark or bloody), and rapid mortality [<a href="#ref-1">1</a>, <a href="#ref-3">3</a>]. Mortality rates can reach 10-50% in untreated flocks [<a href="#ref-1">1</a>]. Birds may die within hours of clinical onset [<a href="#ref-3">3</a>].

### Subclinical Form

Subclinical NE presents with no overt mortality but with reduced feed intake, poor weight gain, and increased feed conversion ratio [<a href="#ref-3">3</a>]. The intestinal mucosa shows mild to moderate necrosis and inflammation [<a href="#ref-3">3</a>]. This form is often undiagnosed but causes significant economic losses [<a href="#ref-3">3</a>].

## Pathology

Gross lesions are primarily confined to the small intestine, particularly the jejunum and ileum [<a href="#ref-1">1</a>, <a href="#ref-3">3</a>]. The intestinal wall is distended, friable, and often covered with a pseudomembrane composed of fibrin, necrotic debris, and bacteria [<a href="#ref-1">1</a>]. The lumen may contain dark, bloody fluid [<a href="#ref-3">3</a>]. The liver may be enlarged and congested [<a href="#ref-1">1</a>].

Histopathological examination reveals coagulative necrosis of the villi, with massive infiltration of heterophils and macrophages [<a href="#ref-1">1</a>, <a href="#ref-5">5</a>]. Gram-positive rods are visible in the necrotic debris [<a href="#ref-1">1</a>]. In chronic cases, fibrosis and regeneration of the epithelium may be observed [<a href="#ref-3">3</a>].

## Diagnostics

Diagnosis of NE is based on clinical signs, gross pathology, histopathology, and microbiological confirmation [<a href="#ref-1">1</a>, <a href="#ref-3">3</a>].

### Microbiological Methods

Isolation of *C. perfringens* from intestinal lesions is confirmatory [<a href="#ref-1">1</a>]. Anaerobic culture on blood agar or selective media (e.g., tryptose-sulfite-cycloserine agar) yields characteristic colonies [<a href="#ref-1">1</a>]. Confirmation of toxigenicity requires detection of alpha-toxin and NetB toxin genes by PCR [<a href="#ref-5">5</a>, <a href="#ref-6">6</a>]. Quantitative PCR can assess bacterial load [<a href="#ref-2">2</a>].

### Histopathology

Histological examination of intestinal sections shows characteristic necrosis and Gram-positive rods [<a href="#ref-1">1</a>]. Immunohistochemistry can detect toxins in tissue [<a href="#ref-5">5</a>].

### Differential Diagnosis

NE must be differentiated from other enteric diseases such as coccidiosis, [ulcerative enteritis](/knowledge/bacteria/avian-bacteria/clostridium-colinum-ulcerative-enteritis-quail-chickens) (*Clostridium colinum*), hemorrhagic enteritis ([turkey adenovirus 3](/knowledge/viruses/avian-viruses/turkey-adenovirus-3)), and salmonellosis [<a href="#ref-1">1</a>, <a href="#ref-3">3</a>]. Concurrent coccidiosis is common [<a href="#ref-4">4</a>].

## Treatment

Treatment of NE is challenging due to the rapid course of the disease [<a href="#ref-1">1</a>]. Antimicrobial therapy is the mainstay, but resistance is increasing [<a href="#ref-6">6</a>].

### Antimicrobial Therapy

Water-soluble antibiotics such as bacitracin, lincomycin, and tylosin are commonly used [<a href="#ref-1">1</a>, <a href="#ref-6">6</a>]. However, the emergence of antimicrobial resistance and regulatory restrictions on antibiotic use in many countries have prompted the search for alternatives [<a href="#ref-6">6</a>, <a href="#ref-10">10</a>].

### Supportive Care

Supportive measures include improving litter quality, reducing stocking density, and providing electrolytes and vitamins [<a href="#ref-3">3</a>]. Removal of predisposing dietary factors is critical [<a href="#ref-2">2</a>].

## Control

Control of NE requires an integrated approach targeting both the pathogen and predisposing factors [<a href="#ref-1">1</a>, <a href="#ref-4">4</a>, <a href="#ref-8">8</a>].

### Biosecurity and Management

Strict biosecurity measures, including all-in/all-out production, proper litter management, and disinfection, reduce environmental contamination [<a href="#ref-1">1</a>]. Avoiding abrupt feed changes and using pelleted feeds can reduce intestinal viscosity [<a href="#ref-2">2</a>].

### Coccidiosis Control

Since coccidiosis is a major predisposing factor, effective control of *Eimeria* through vaccination or anticoccidial drugs is essential [<a href="#ref-4">4</a>, <a href="#ref-8">8</a>]. Live attenuated vaccines are widely used [<a href="#ref-8">8</a>].

### Dietary Interventions

Dietary modifications include reducing levels of animal protein and non-starch polysaccharides, and supplementing with enzymes (e.g., xylanase) to reduce intestinal viscosity [<a href="#ref-2">2</a>]. Organic acids and medium-chain fatty acids have shown inhibitory effects against *C. perfringens* [<a href="#ref-10">10</a>].

### Probiotics and Prebiotics

Probiotics, particularly *Bacillus* and *Lactobacillus* species, can competitively exclude *C. perfringens* and modulate the immune response [<a href="#ref-9">9</a>, <a href="#ref-10">10</a>]. Prebiotics such as mannan-oligosaccharides and fructo-oligosaccharides promote beneficial gut bacteria [<a href="#ref-9">9</a>].

### Vaccination

Vaccines against NE have been developed, including toxoid vaccines targeting alpha-toxin and NetB, as well as bacterin vaccines [<a href="#ref-5">5</a>, <a href="#ref-6">6</a>]. Maternal antibodies can provide passive protection to chicks [<a href="#ref-5">5</a>]. However, vaccine efficacy in the field remains variable [<a href="#ref-6">6</a>].

### Alternatives to Antibiotics

Given the global push to reduce antibiotic use, alternatives such as bacteriophages, antimicrobial peptides, and plant-derived compounds (e.g., essential oils) are under investigation [<a href="#ref-10">10</a>]. Bacteriophages specific to *C. perfringens* have shown promise in experimental models [<a href="#ref-10">10</a>].

## Decision Tree for [Necrotic Enteritis](/knowledge/bacteria/avian-bacteria/poultry-necrotic-enteritis-pathogenesis-control) Diagnosis and Control

The following Mermaid diagram outlines a diagnostic and control decision tree for suspected NE outbreaks.

```mermaid
flowchart TD
 A["Clinical signs: depression, diarrhea, mortality"] --> B{"Postmortem examination"}
 B --> C["Intestinal necrosis, pseudomembrane"]
 C --> D["Histopathology: coagulative necrosis, Gram+ rods"]
 D --> E["Anaerobic culture and PCR for toxin genes"]
 E --> F{"Confirmation of NE"}
 F -->|"Positive"| G["Implement treatment: antibiotics + supportive care"]
 F -->|"Negative"| H["Consider differentials: coccidiosis, ulcerative enteritis, salmonellosis"]
 G --> I["Identify predisposing factors"]
 I --> J["Coccidiosis control"]
 I --> K["Dietary management"]
 I --> L["Probiotic supplementation"]
 J --> M["Vaccination or anticoccidials"]
 K --> N["Reduce NSP, add enzymes"]
 L --> O["Use Bacillus/Lactobacillus products"]
 M --> P["Monitor flock performance"]
 N --> P
 O --> P
 P --> Q{"Recurrence?"}
 Q -->|"Yes"| R["Review biosecurity and management"]
 Q -->|"No"| S["Maintain integrated control program"]
```

## Conclusion

[Necrotic enteritis](/knowledge/bacteria/avian-bacteria/necrotic-enteritis-poultry) remains a major challenge in poultry production, particularly in the post-antibiotic growth promoter era [<a href="#ref-4">4</a>, <a href="#ref-6">6</a>]. The disease is a classic example of a multifactorial condition requiring a holistic control approach [<a href="#ref-1">1</a>]. Advances in understanding the molecular pathogenesis, particularly the role of NetB toxin, have opened new avenues for vaccine development [<a href="#ref-5">5</a>, <a href="#ref-6">6</a>]. Integrated strategies combining biosecurity, coccidiosis control, dietary management, probiotics, and vaccination offer the best prospects for sustainable control [<a href="#ref-8">8</a>, <a href="#ref-9">9</a>, <a href="#ref-10">10</a>]. Continued research into the gut microbiome and host-pathogen interactions will further refine these strategies [<a href="#ref-2">2</a>, <a href="#ref-9">9</a>].

## References

<a id="ref-1"></a>[<a href="#ref-1">1</a>] Swayne DE, Boulianne M, Logue CM, et al. Diseases of Poultry. 14th ed. Wiley-Blackwell; 2020.

<a id="ref-2"></a>[<a href="#ref-2">2</a>] Stanley D, Hughes RJ, Moore RJ. Microbiota of the chicken gastrointestinal tract: influence on health, productivity and disease. Applied Microbiology and Biotechnology. 2014;98(10):4301-4310.

<a id="ref-3"></a>[<a href="#ref-3">3</a>] McDevitt RM, Brooker JD, Acamovic T, et al. [Necrotic enteritis](/knowledge/bacteria/avian-bacteria/poultry-necrotic-enteritis-pathogenesis-control); a continuing challenge for the poultry industry. World's Poultry Science Journal. 2006;62(2):221-247.

<a id="ref-4"></a>[<a href="#ref-4">4</a>] Williams RB. Intercurrent coccidiosis and [necrotic enteritis](/knowledge/bacteria/avian-bacteria/necrotic-enteritis-poultry) of chickens: rational, integrated disease management by maintenance of gut integrity. Avian Pathology. 2005;34(3):159-180.

<a id="ref-5"></a>[<a href="#ref-5">5</a>] Keyburn AL, Boyce JD, Vaz P, et al. NetB, a new toxin that is associated with avian [necrotic enteritis](/knowledge/bacteria/avian-bacteria/poultry-necrotic-enteritis-pathogenesis-control) caused by Clostridium perfringens. PLoS Pathogens. 2008;4(2):e26.

<a id="ref-6"></a>[<a href="#ref-6">6</a>] Van Immerseel F, Rood JI, Moore RJ, et al. Rethinking our understanding of the pathogenesis of [necrotic enteritis in chickens](/knowledge/bacteria/avian-bacteria/necrotic-enteritis-in-chickens). Trends in Microbiology. 2009;17(1):32-36.

<a id="ref-7"></a>[<a href="#ref-7">7</a>] Merck Veterinary Manual. 11th ed. Merck & Co.; 2016.

<a id="ref-8"></a>[<a href="#ref-8">8</a>] Chapman HD. Practical use of vaccines for the control of coccidiosis in the chicken. World's Poultry Science Journal. 2000;56(1):7-20.

<a id="ref-9"></a>[<a href="#ref-9">9</a>] Gaggìa F, Mattarelli P, Biavati B. Probiotics and prebiotics in animal feeding for safe food production. International Journal of Food Microbiology. 2010;141(Suppl 1):S15-S28.

<a id="ref-10"></a>[<a href="#ref-10">10</a>] Caly DL, D'Inca R, Auclair E, et al. Alternatives to antibiotics to prevent [necrotic enteritis in broiler chickens](/knowledge/bacteria/avian-bacteria/necrotic-enteritis-broiler-clostridium-perfringens-virulence-microbiome-probiotics): a microbiologist's perspective. Frontiers in Microbiology. 2015;6:1336.

## Related Clinical & Scientific Guides

* [Duck Diseases: A Comprehensive Overview for Veterinary Practitioners](/knowledge/bacteria/general/duck-diseases-comprehensive-overview-veterinary)
* [Salmonella Dublin in Cattle: Emerging Pathogen, Diagnostic Challenges, and Public Health Impact](/knowledge/bacteria/general/salmonella-dublin-cattle-emerging-pathogen-diagnostic-public-health)
* [Mycoplasma Infections in Poultry: Vaccination Strategies and Control Programs](/knowledge/bacteria/general/mycoplasma-infections-in-poultry-vaccination-strategies-and-control-programs)